Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aztreonam”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Early research (Phase 1)Study completedNCT01689207
What this trial is testing

To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)

Who this might be right for
Complicated InfectionBacterial Infections
Pfizer 222
Not applicableApproved For MarketingNCT00499720
What this trial is testing

Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa Airway Infection
Gilead Sciences
Testing effectiveness (Phase 2)Study completedNCT01375049
What this trial is testing

Aztreonam Lysine for Pseudomonas Infection Eradication Study

Who this might be right for
Cystic Fibrosis
Gilead Sciences 105
Testing effectiveness (Phase 2)Study completedNCT02453789
What this trial is testing

OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection

Who this might be right for
Cystic FibrosisBurkholderia Infection
AlgiPharma AS 15
Large-scale testing (Phase 3)Study completedNCT01984684
What this trial is testing

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsSkin Structures and Soft Tissue Infections
Melinta Therapeutics, Inc. 850
Large-scale testing (Phase 3)Study completedNCT00112359
What this trial is testing

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

Who this might be right for
Cystic Fibrosis
Gilead Sciences 166
Post-approval studies (Phase 4)Ended earlyNCT03696290
What this trial is testing

Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis

Who this might be right for
Bronchiectasis Adult
University of Dundee 34
Post-approval studies (Phase 4)Looking for participantsNCT07478484
What this trial is testing

Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB

Who this might be right for
Ceftazidime-avibactamAztreonamGram-negative Bacterial Infection+2 more
Jing Zhou 144
Testing effectiveness (Phase 2)Looking for participantsNCT05639647
What this trial is testing

Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Who this might be right for
Gram-negative Bacterial Infections
Pfizer 48
Not applicableStudy completedNCT06419296
What this trial is testing

Mortality of MBL-producing Enterobacteriaceae Bacteremias with the Combined Use of Ceftazidime-avibactam and Aztreonam Vs. Other Active Antibiotics. a Multicenter Target Trial Emulation.

Who this might be right for
Bacteremia
Hospital Italiano de Buenos Aires 265
Large-scale testing (Phase 3)Study completedNCT01641822
What this trial is testing

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Who this might be right for
Cystic Fibrosis
Gilead Sciences 107
Large-scale testing (Phase 3)Study completedNCT01059565
What this trial is testing

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection

Who this might be right for
Cystic FibrosisBurkholderia Infections
Gilead Sciences 102
Testing effectiveness (Phase 2)Study completedNCT03978091
What this trial is testing

A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam

Who this might be right for
Bacterial Infection
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00805025
What this trial is testing

Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis

Who this might be right for
Bronchiectasis
Gilead Sciences 89
Large-scale testing (Phase 3)Study completedNCT00423657
What this trial is testing

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

Who this might be right for
Bacterial Infections
Forest Laboratories 680
Large-scale testing (Phase 3)Study completedNCT00128492
What this trial is testing

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

Who this might be right for
Cystic Fibrosis
Gilead Sciences 274
Not applicableStudy completedNCT01375036
What this trial is testing

Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Gilead Sciences 510
Not applicableStudy completedNCT01460836
What this trial is testing

Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT05905055
What this trial is testing

P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales

Who this might be right for
Complicated Urinary Tract InfectionAcute PyelonephritisHospital-acquired Bacterial Pneumonia+2 more
Meiji Seika Pharma Co., Ltd. 126
Not applicableApproved For MarketingNCT00989807
What this trial is testing

Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Gilead Sciences
Load More Results